These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6898782)

  • 1. [Parkinsonism].
    Kadykov AS
    Med Sestra; 1980 Jan; 39(1):21-4. PubMed ID: 6898782
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of parkinsonism.
    Godwin-Austen R
    Practitioner; 1975 Oct; 215(1288):445-51. PubMed ID: 1202468
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current drug treatment of parkinsonism].
    Kistenev BA; Kadykov AS; Pivovarova VM
    Sov Med; 1976 Nov; (11):57-61. PubMed ID: 1006394
    [No Abstract]   [Full Text] [Related]  

  • 4. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)].
    Shiozawa R; Kase M; Kuroiwa Y; Narabayashi H; Nishitani Y; Ohmoto T; Toyokura Y; Uono K
    No To Shinkei; 1981 Mar; 33(3):301-9. PubMed ID: 7018522
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of Parkinsonism. II].
    Clin Ter; 1974 Nov; 71(4):367-87. PubMed ID: 4617648
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of parkinsonism].
    Parkenberg H
    Ugeskr Laeger; 1976 Apr; 138(18):1104-5. PubMed ID: 1265907
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy of parkinsonism].
    Teräväinen H; Larsen TA
    Duodecim; 1982; 98(11):892-900. PubMed ID: 6125373
    [No Abstract]   [Full Text] [Related]  

  • 8. [L-dopa-induced movement disorders in Parkinson disease. Amantadine improves dyskinesia].
    MMW Fortschr Med; 2001 May; 143 Suppl 2():93. PubMed ID: 11434272
    [No Abstract]   [Full Text] [Related]  

  • 9. [Amantadine in the therapy of Parkinson syndromes].
    Pfaff G
    Med Klin; 1980 Oct; 75(22):792-4. PubMed ID: 7453628
    [No Abstract]   [Full Text] [Related]  

  • 10. [Parkinsonism].
    Kaumeier S
    Fortschr Med; 1978 Jul; 96(28):1397-404. PubMed ID: 27434
    [No Abstract]   [Full Text] [Related]  

  • 11. Amantadine for levodopa resistant parkinsonism.
    Sandyk R; Iacono RP; Snider SR
    Int J Neurosci; 1987 Feb; 32(3-4):715-7. PubMed ID: 3596918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apomorphine test: evaluation of dopaminergic response in patients with Parkinson disease].
    Miranda M; Saéz D
    Rev Med Chil; 1995 Mar; 123(3):326-9. PubMed ID: 8525172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center].
    Antonini FM; Baroni A
    Minerva Med; 1971 Oct; 62(82):4027-30. PubMed ID: 5125072
    [No Abstract]   [Full Text] [Related]  

  • 14. Parkinsonism as a falling sickness.
    Klawans HL; Topel JL
    JAMA; 1974 Dec; 230(11):1555-7. PubMed ID: 4479664
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of parkinsonism with L-Dopa and amantadine.
    Green J
    J Fla Med Assoc; 1970 Jun; 57(6):28-33. PubMed ID: 5445813
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic effects of amantadine hydrochloride on manifestations of parkinsonism].
    Espadaler Medina JM; Olivella Rius J; Ruscadella Nadal J
    Rev Esp Otoneurooftalmol Neurocir; 1969-1970; 28(164):236-46. PubMed ID: 5398580
    [No Abstract]   [Full Text] [Related]  

  • 17. Early idiopathic parkinsonism: initiation and optimization of treatment.
    Calne DB
    Clin Neuropharmacol; 1994; 17 Suppl 2():S14-8. PubMed ID: 9358191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personal experience with a combination of drugs in subjects with dopa resistant Parkinson's disease.
    Mastrosimone F; Colucci d'Amato C; De Angelis G; Iaccarino C; Giordano L; Marmo E
    J Med; 1980; 11(5-6):377-83. PubMed ID: 6962824
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current treatment of Parkinsonism with amantadine hydrochloride].
    Gerstenbrand F; Gründig E; Musiol A
    Pol Tyg Lek; 1972 Jul; 27(23):878-9. PubMed ID: 5040531
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient].
    Ceballos-Baumann AO
    MMW Fortschr Med; 2002 May; Suppl 2():37-43. PubMed ID: 12070848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.